Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Lonza Underlying Revenue Up 5.6% In 2011; Announces CEO Transition - Update

Chemical and biotechnological supplier Lonza Group (LZAGF.PK) on Wednesday reported growth in underlying revenue and EBITDA for 2011 at constant exchange rates due to high capacity utilization in most business units. Further, the company's board has decided to change chief executive Stefan Borgas. Chairman Rolf Soiron will co-ordinate the Management Committee during the transition.

Before the recent acquisition of Arch Chemicals, revenues grew 5.6 percent at constant exchange rates to 2.505 billion Swiss francs. Foreign exchange had a negative impact of 84 million francs. EBIT before acquisition was 292 million francs.

The Custom Manufacturing business continued to benefit from demand for outsourcing from pharmaceutical and biotech companies, while the Microbial Control business saw a slowdown in established markets from the third quarter of the year.

The Board of Directors proposed a cash dividend of 2.15 francs per share for 2011. The Lonza Board will be increased from seven to eight members. Margot Scheltema and Dr. Jörg Reinhardt were proposed as new Board members, while Dame Julia Higgins would leave the board.

In 2012, the acquisition of Arch is expected to deliver overall earnings growth that would translate into significant earnings per share growth as well.

Commenting on the change of CEO, Rolf Soiron, Chairman of the Board of Lonza, said, "...continuous change characterized the past years and Stefan Borgas has led this process as Lonza's CEO...In the challenging years ahead Lonza will enter a period of focus and improvement of return of capital. This led the Board of director's to the decision to initiate a change of CEO. As Chairman of the Board I will lead the Management Committee during the transition."

The stock closed in Zurich on Tuesday lower by 0.24 percent at 61.20 euros on 192,652 shares.

Register
To receive FREE breaking news email alerts for Lonza Group and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.